Join AEI as an expert panel reviews the most consequential twists and turns in the post-enactment regulation, litigation, and administration of the Affordable Care Act.
History shows that the primary beneficiaries of voluntary price restraint announcements from the drug industry might just just be drug companies themselves.
While the book may not really solve our various health-policy problems, it at least insists that it is trying to help.
There is a significant demand for medication, and if it cannot be satisfied by the legal market less legal sources will be found.
Three experts discuss strategies to address the shortage of organs available for people who need transplants
In order to curb the high price of health care, the American health system must learn to achieve efficiency and effectiveness for the services it delivers. While there are no shortage of ideas about how to do so, there has certainly been a lack of success.
With the stated aim of increasing revenue and discouraging smoking, Pakistan raised tobacco duties over the past five years. The result empowered illicit actors, with a flourishing of illicit production and smuggling of cigarettes.
While the CBO’s ne forecast looks in many ways quite similar to previous projections, the agency has revised its views on one very important aspect of its forecast— the individual mandatwe.
Join AEI as the chief actuary for Medicare summarizes the 2018 Medicare Trustees Report, followed by a discussion of potential policy actions to improve the program’s fiscal condition.
Ask not why a proposed merger might harm someone somewhere under some hypothetical set of conditions, a question utterly inconsistent with the creative destruction that is the very nature of competitive free enterprise. Ask instead how it might reduce costs and improve services in the world in which we actually live.
Some rural health care, broadband, and edge providers that are concerned the FCC’s broadband subsidies program is inadequate, but blockchain and smart contracts may provide some answers.
Democrats in Washington managed to take an issue that unified literally thousands of legislators from both parties in 40 states, and turned it into a divisive, party-line vote. But thanks to President Trump, Americans facing terminal diagnoses will now have a new chance at life.